Axsome Therapeutics Inc. News
Latest updates and market news for AXSM
3 news
Mar 11 - Mar 17, 2026
Page 1
Zacks
AXSM's 2025 Revenue Surge Largely Driven by Auvelity: What's Ahead?
📊
AI Sentiment
Positive
6/10
MarketBeat
Axsome Therapeutics Highlights Auvelity’s $500M+ Run, FDA Catalyst and Late-Stage Pipeline at Conference
📈
AI Sentiment
Highly Positive
9/10
Share this news page